达格列净联合二甲双胍治疗肥胖2型糖尿病的临床效果(4)
[10]Ogurtsova K，da Rocha Fernandes JD，Huang Y，et al.IDF diabetes atlas：global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract，2017， 128：40-50.
[11]中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J]中华内分泌代谢杂志，2016，32(8)：623-627.
[12]Indulekha K，Anjana RM，Surendar J，et al.Association of visceral and subcutaneous fat with glucose intolerance，insulin resistance，adipocytokines and inflammatory markers in Asian Indians (CURES-113)[J].Clin Biochem，2011，44(4)：281-287.
[13]Zaccardi F，Webb DR，Htike ZZ，et al.Effcacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus：systematic review and network meta-analysis[J].Diabetes Obes Metab，2016，18(8)：783-794.
[14]Pradeepa R，Mohan V.Prevalence of type 2 diabetes and its complications in India and economic costs to the nation[J].Eur J Clin Nutr，2017，71(7)：816-824.
[15]Kuwabara M，Niwa K，Hisatome I，et al.Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases：five-year Japanese cohort study[J].Hypertension，2017，69(6)：1036-1044.
[16]Nagano S，Takahashi M，Miyai N，et al.Association of serum uric acid with subsequent arterial stiffness and renal function in normotensive subjects[J].Hypertens Res，2017，40(6)：620-624.
[17]Li ZJ，Yi CJ，Li J，et al.Serum uric acid level as a cardio-cerebrovascular event risk factor in middle-aged and non-obese Chinese men[J].Oncotarget，2017，8(15)：24 110-24 118.
(收稿日期：2018-10-11 本文編辑：刘克明), http://www.100md.com(谢万均 于鑫淼 田丰秋)
[11]中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J]中华内分泌代谢杂志，2016，32(8)：623-627.
[12]Indulekha K，Anjana RM，Surendar J，et al.Association of visceral and subcutaneous fat with glucose intolerance，insulin resistance，adipocytokines and inflammatory markers in Asian Indians (CURES-113)[J].Clin Biochem，2011，44(4)：281-287.
[13]Zaccardi F，Webb DR，Htike ZZ，et al.Effcacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus：systematic review and network meta-analysis[J].Diabetes Obes Metab，2016，18(8)：783-794.
[14]Pradeepa R，Mohan V.Prevalence of type 2 diabetes and its complications in India and economic costs to the nation[J].Eur J Clin Nutr，2017，71(7)：816-824.
[15]Kuwabara M，Niwa K，Hisatome I，et al.Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases：five-year Japanese cohort study[J].Hypertension，2017，69(6)：1036-1044.
[16]Nagano S，Takahashi M，Miyai N，et al.Association of serum uric acid with subsequent arterial stiffness and renal function in normotensive subjects[J].Hypertens Res，2017，40(6)：620-624.
[17]Li ZJ，Yi CJ，Li J，et al.Serum uric acid level as a cardio-cerebrovascular event risk factor in middle-aged and non-obese Chinese men[J].Oncotarget，2017，8(15)：24 110-24 118.
(收稿日期：2018-10-11 本文編辑：刘克明), http://www.100md.com(谢万均 于鑫淼 田丰秋)